Tag: OTC:KHRNF

November 11, 2019

Khiron Receives Approval to Sell Aceso™ Hemp CBD Brand in Colombia

Khiron Life Sciences Corp. (TSXV: KHRN, OTCQB: KHRNF, Frankfurt: A2JMZC) will introduce the Aceso™ Hemp brand to the Latin America...
November 6, 2019

Khiron Enters First Latin American Cannabis Lines of Research Targeting U.S. $44 Billion Dermatological Drug Market

Khiron Life Sciences Corp. presented their cannabis dermatological lines of research at II TeraCILAD in Colombia.
November 4, 2019

Khiron Appoints Veteran Independent Director Deborah Rosati FCPA, FCA, ICD.D

Khiron Life Sciences Corp. announces that Deborah Rosati FCPA, FCA, ICD.D has been appointed effective immediately to the Board of...
November 1, 2019

Khiron To Participate in Cowen 2nd Annual Boston Cannabis Conference

Khiron Life Sciences Corp. is pleased to announce its participation in the Cowen 2nd Annual Boston Cannabis Conference in Boston, MA.
October 31, 2019

Khiron to Host Live Investor Webcast on November 5, 2019

Khiron Life Sciences is pleased to announce that President, Chris Naprawa, will present live at Grit Capital's Webcast Series on November 5th, 2019.
October 25, 2019

Kuida is One Year Old! First Export to the US Market, UK Product Approval, and 300+ Points of Sale in Colombia

Khiron announced that the Company adds another significant milestone: its first import of Kuida cosmetic products into the United States.
October 22, 2019

Draft Legislation Offers Preview of Cannabis Market in Mexico

The legislation lays out the framework for Mexico's cannabis laws, which could the largest legal cannabis market in the world...